COMMUNIQUÉS West-GlobeNewswire

BioTelemetry, Inc. to Release Second Quarter 2018 Earnings Results on July 25, 2018
17/07/2018
MALVERN, Pa., July 17, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2018 earnings on Wednesday, July 25 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call [...]
Axsome Therapeutics Announces AXS-05 Presentation at the 2018 Alzheimer’s Association International Conference
17/07/2018
NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Capricor and USAISR Announce Collaboration to Investigate Exosome Platform to Treat Injured Troops
17/07/2018
Research to Explore Potential for CAP-2003 to Address Trauma-related Injuries LOS ANGELES, July 17, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) today announced it has entered into an agreement with the [...]
Auxly Congratulates Streaming Partner CannTx Life Sciences on Obtaining Cultivation Licence
17/07/2018
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to announce that Auxly’s streaming partner, CannTx Life Sciences Inc. (“ [...]
APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer
17/07/2018
The Former CEO, Dr. Hans Loibner, Will Continue to Support the Company as Senior Advisor VIENNA, Austria, July 17, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today [...]
PotNetwork Holdings, Inc., With Sales of Over $10 Million Year-To-Date, Moves Toward Uplisting and Expansion
17/07/2018
FT. LAUDERDALE, Fla., July 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC Pink:POTN) on July 13 th , the Company announced that it had filed a Form 10 registration statement with the [...]
Transactions in relation to share buyback program
17/07/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at AAIC in Chicago
17/07/2018
Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at the Alzheimer's Association International Conference in Chicago Lausanne, [...]
Enzymatica AB: Lower sales in Q2 but 31% increase for the first half of the year
17/07/2018
Interim report for Enzymatica AB (publ) JANUARY-JUNE 2018 Lower sales in Q2 but 31% increase for the first half of the year Q2 Net sales reached SEK 5.3 (5.9) million. Net profit after tax came in at SEK -15.5 (-10.8) [...]
CellaVision AB: Interim Report January-June 2018
17/07/2018
Good sales growth in all regions April 1-June 30, 2018 Net sales increased by 17% to SEK 91.9 million (78.7). Organic growth was 15%. Operating profit was SEK 31.6 million (24.6). Operating margin was 34.4% (31.3). [...]
Terveystalo Plc: The Finnish Competition and Consumer Authority initiates further proceedings concerning the transaction between Terveystalo and Attendo
17/07/2018
Terveystalo Plc Stock Exchange release 17 July 2018 at 09.00 a.m. EEST Terveystalo Plc ("Terveystalo") has on 17 May 2018 signed an agreement to acquire the Finnish healthcare operations of Attendo AB (publ) ("Attendo [...]
Shire plc : Rule 2.9 Announcement
17/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 17 July 2018 Shire [...]
Nicox : Point d'activité et résumé financier du second trimestre 2018
17/07/2018
Communiqué de presse Nicox : Point d'activité et résumé financier du second trimestre 2018 .............................................. 17 juillet 2018 - diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext [...]
Nicox Second Quarter 2018 Business Update and Financial Highlights
17/07/2018
Press Release Nicox Second Quarter 2018 Business Update and Financial Highlights .............................................. July 17, 2018 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: [...]
argenx receives milestone payment from strategic collaboration with Shire
17/07/2018
July 17, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Biocartis Group NV: Biocartis launches innovative Idylla(TM) MSI Assay
17/07/2018
PRESS RELEASE : 17 July 2018, 07:00 CEST Biocartis launches innovative Idylla(TM) MSI Assay Idylla(TM) MSI Assay further strengthens Biocartis' test menu and offers opportunities to enter the immuno-oncology testing [...]
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/07/2018
WALTHAM, Mass., July 16, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Compensation Committee of the Company’s Board of Directors granted Chhaya Shah, in [...]
GenMark Diagnostics Schedules Second Quarter Financial Results Conference Call for July 30, 2018
16/07/2018
CARLSBAD, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, July 30, 2018. [...]
Clearside Biomedical to Present Data from its Pivotal Phase 3 (“PEACHTREE”) Trial in Macular Edema Associated with Uveitis at the 2018 American Society of Retina Specialists Annual Meeting
16/07/2018
Late-Breaker Oral Presentation on Wednesday, July 25 ALPHARETTA, Ga., July 16, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside”), (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing [...]

Pages